| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytek Biosciences, Inc. (CTKB) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. CTKB is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.39M | $21.36M | - | |
| Other | 4.92M | $19.48M | - | |
| Other | 121.4K | $480.6K | - | |
| CFO | 87.0K | $344.7K | - | |
| Dir | 55.6K | $220.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $10.06 | $201,200.00 | -0.2% | +27.0% | -16.9% | |
| Jun 7, 2022 | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $10.75 | $215,000.00 | -0.3% | +14.0% | -24.6% | |
| May 19, 2022 | Yan Ming77 | Chief Technology Officer | Sale+OE | 20,000 | $9.92 | $198,400.00 | -0.2% | +43.4% | -28.4% | |
| May 9, 2022 | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $8.01 | $160,200.00 | -0.3% | +92.2% | +49.2% | |
| Apr 19, 2022 | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $10.34 | $206,800.00 | -0.2% | +10.1% | -6.4% | |
| Apr 7, 2022 | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $10.54 | $210,800.00 | -0.3% | +3.5% | -15.8% | |
| Mar 21, 2022 | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $11.64 | $232,800.00 | -0.2% | -12.4% | -17.7% | |
| Mar 15, 2022 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 583,870 | $12.31 | $7,188,925.62 | +2.3% | -19.2% | -20.4% | |
| Mar 11, 2022 | Ra Capital Management, L.P.52 | Director | Buy | 634,638 | $12.86 | $8,158,670.96 | +1.7% | -16.0% | -26.7% | |
| Mar 8, 2022 | Ra Capital Management, L.P.52 | Director | Buy | 647,264 | $12.74 | $8,248,254.64 | +1.8% | -17.1% | -24.2% |